FeaturesSignalPricingFounders
Log inGet started free
KH

KBL Healthcare Ventures

Venture CapitalActive

KBL is a venture capital firm dedicated to investing in early stage and emerging growth healthcare companies.

New York, United StatesFounded 2006
15
Investments
8
Exits
—
AUM
53.3%
Exit Rate

Get contact info, warm intros & fit scores

Sign up to unlock emails, Signal intro paths, and personalized fit analysis for KBL Healthcare Ventures.

Get started free

Investment Thesis & Strategy

KBL Healthcare Ventures invests in early-stage and emerging growth companies within the biotech, fintech, and healthcare sectors. They focus on companies with high growth potential and innovative solutions.

Investment Activity

Deals per year over the last 6 years

1
2019
4
2020
1
2021
2
2022
2
2023
2
2024

Portfolio Companies

Selected investments from their portfolio of 15 companies

A
Aegle Therapeutics
Biotech · Growth, 2024
Active
T
Tarsus Pharmaceuticals
Healthcare · Growth, 2024
Active
A
Aegle Therapeutics
Biotech · Series C+, 2023
Active
T
Tarsus Pharmaceuticals
Healthcare · Growth, 2023
Active
T
Tarsus Pharmaceuticals
Healthcare · Growth, 2022
Active
A
Aegle Therapeutics
Biotech · Series B, 2022
Active
T
Tarsus Pharmaceuticals
Healthcare · Growth, 2021
Active
V
Vaxart
Biotech · Growth, 2020
Active
A
Aegle Therapeutics
Biotech · Series A, 2020
Active
T
Tarsus Pharmaceuticals
Healthcare · Growth, 2020
Active
A
Aegle Therapeutics
Biotech · Series A, 2020
Active
V
Vaxart
Biotech · Series C+, 2019
Active

Frequently Asked Questions

KBL Healthcare Ventures focuses on Series A, Series B, Series C+ stage investments.

Related Investors

Goldman Sachs

New York, United States · 780 deals

Greycroft

New York, United States · 559 deals

RRE Ventures

New York, United States · 498 deals

Lerer Hippeau

New York, United States · 470 deals

Insight Partners

New York, United States · 446 deals

Tiger Global Management

New York, United States · 442 deals